Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Bicalutamide may help treat female pattern hair loss.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Finasteride may improve prostate cancer treatment outcomes.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Mutations in certain receptors can cause diseases and offer new treatment options.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Topical finasteride may help treat facial hirsutism in women.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.